Crelux has developed a bi-turbo vector system which allows to express target proteins in parallel in E.coli and insect cells from the same plasmid construct. This procedure helps to produce pure proteins for x-ray structure analysis and for drug discovery purposes. The acquisition is in line with the rapid development of WuXi European operations.

China Bio news release, April 20, 2016